Adam Wagner
Get their honest, personalized take on your startup.
Sign in to pitch Adam →At a glance
- Full Name
- Adam R. Wagner
- Title
- Chief Operating Officer
- Firm
- Blue Jay Capital Management, LLC
- Firm Type
- Healthcare-focused long/short equity hedge fund (public-markets / SEC-registered investment adviser) — not an angel/seed investor
- Investment Stage
- Public equities (healthcare & life sciences). *Note: the supplied stub labeled him an "Angel Investor" investing in "Seed Rounds"; research does not support this. Blue Jay is a public-equity hedge fund, and Wagner is its operating/IR executive rather than a startup angel investor.*
- Sector Focus
- Healthcare / life sciences / biotech
- Geographic Focus
- United States (public equities)
- Location
- 2121 Avenue of the Stars, Suite 2980, Los Angeles, CA 90067
Background
Adam R. Wagner is the Chief Operating Officer of Blue Jay Capital Management, LLC, a Los Angeles–based hedge fund manager that runs long/short equity portfolios focused on the healthcare and life-sciences sector. In this role he is responsible for the firm's daily trading operations, marketing, and investor-relations functions. He joined Blue Jay in 2013.
Before Blue Jay, Wagner spent his career in prime brokerage and hedge-fund servicing. He was a Vice President at Pershing LLC (a BNY Mellon company), where he was a senior member of the Sales and Relationship Management group within Pershing Prime Services, responsible for establishing and maintaining prime brokerage and financing relationships with hedge funds, mutual funds, and other alternative managers. Earlier, he served as a Relationship Manager in the prime brokerage divisions of J.P. Morgan and Bear Stearns. Public sources indicate he holds a Bachelor of Science in Finance from Villanova University.
Beyond his firm, Wagner has been active in the industry's institutional community: he was elected as a Director on the Board of the California Hedge Fund Association (CHFA, now CalALTs / California Alternative Investments Association), announced in March 2016, where the association's leadership cited his "knowledge and depth of experience."
Blue Jay Capital Management is a small-to-mid-sized manager, reported at roughly $274.7 million in total assets under management across three private funds — the Blue Jay Health Sciences Master Fund LP, Blue Jay Health Sciences Fund LP, and Blue Jay Health Sciences Fund Ltd — consistent with a dedicated healthcare/biotech long-short strategy.
Investment Thesis & Focus
- Invests in public healthcare and life-sciences equities through a long/short equity strategy — this is a hedge-fund mandate, not venture or angel investing.
- Capital is deployed via pooled private funds (a master-feeder structure: onshore LP feeder, offshore Ltd feeder, and a master fund), not via startup equity checks.
- Firm scale (~$275M AUM) points to a focused, sector-specialist book rather than a broad generalist fund.
- As COO, Wagner's remit centers on operations, trading operations, marketing, and investor relations rather than making portfolio stock-selection or startup-funding decisions. Founders seeking seed capital are outside this firm's mandate.
Notable Investments
- Blue Jay is a public-markets manager, so its "investments" are disclosed equity positions rather than named startup rounds. Its long U.S. equity holdings are reported quarterly on SEC Form 13F (available via the SEC EDGAR database and aggregators such as WhaleWisdom). Specific current holdings were not verifiable from the sources reviewed and are therefore not listed here to avoid fabrication.
- Fund vehicles the firm manages: Blue Jay Health Sciences Master Fund LP, Blue Jay Health Sciences Fund LP, and Blue Jay Health Sciences Fund Ltd — all healthcare/life-sciences focused.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.